Lorazepam
Lorazepam is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Lorazepam; Generic name: LORAZEPAM; Drug class: Benzodiazepine [EPC].
| Brand name | Lorazepam |
|---|---|
| Generic name | LORAZEPAM |
| Drug class | Benzodiazepine [EPC] |
| Manufacturer | Aphena Pharma Solutions - Tennessee, LLC |
| Used for | INDICATIONS AND USAGE Lorazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient. |
| Dosage | DOSAGE AND ADMINISTRATION Lorazepam is administered orally. For optimal results, dose, frequency of administration, and duration of therapy should be individualized according to patient response. To facilitate this, 0.5 mg, 1 mg, and 2 mg tablets are available. The usual range is 2 to 6 mg/day given in divided doses, the largest dose being taken before bedtime, but the daily dosage may vary from 1 to 10 mg/day. For anxiety, most patients require an initial dose of 2 to 3 mg/day given two times a |
| Warnings | WARNINGS Concomitant use of benzodiazepines, including Lorazepam, and opioids may result in profound sedation, respiratory depression, coma, and death. Because of these risks, reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate. Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioids alone. If a decision is made |
| Active ingredient(s) | LORAZEPAM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08bd30b0-a1c1-4ec3-bb9c-b1d55ac59f75 |